title: Good news for 'good' cholesterol.
authors.forename: Alla
authors.initials: A
authors.lastname: Katsnelson
mesh_terms: D000577:Amides; D002097:C-Reactive Protein / Q000032:analysis; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D008076:Cholesterol, HDL / Q000032:analysis / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000032:analysis / Q000378:metabolism; D002986:Clinical Trials as Topic; D004952:Esters; D006331:Heart Diseases / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D023303:Oxazolidinones / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011804:Quinolines / Q000009:adverse effects; D013438:Sulfhydryl Compounds
chemical_list: D000577:Amides; C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004952:Esters; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D023303:Oxazolidinones; D011804:Quinolines; D013438:Sulfhydryl Compounds; C411602:dalcetrapib; C483909:torcetrapib; D002097:C-Reactive Protein; C530884:anacetrapib